Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Preventive Medicine Reports|June 6, 2018
High rates of cancer screening among dialysis patients seen in primary care a cohort studyBjorg Thorsteinsdottir, LaTonya J Hickson, Priya Ramar, et al.
Mayo Clinic Proceedings|September 4, 2022
Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019Raymund R Razonable, John C O'Horo, Douglas W Challener, et al.
Trials|December 17, 2009
Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practiceLaurie J Pencille, Megan E Campbell, Holly K Van Houten, et al.
Eclinicalmedicine|September 6, 2021
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19Raymund R Razonable, Colin Pawlowski, John C O'Horo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19Ravindra Ganesh, Colin Pawlowski, John C O'Horo, et al.
The Journal of Infectious Diseases|July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
The Journal of Clinical Investigation|August 19, 2021
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19Ravindra Ganesh, Colin F Pawlowski, John C O'Horo, et al.
Mbio|April 11, 2024
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19Juan G Ripoll, Sidna M Tulledge-Scheitel, Anthony A Stephenson, et al.
Frontiers in Medicine|November 3, 2025
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysisSolomiia Zaremba, Daniele Focosi, Wyatt W Pruter, et al.
Pageof 4